If you want to distinguish your goods, services or both from those of another company, you may need a trademark or trade name. Find out what they are, what their registration procedure is and what it involves.
Information on the deadlines for filing applications for transformation of European Union trademarks into Spanish national trademarks. See more
If you have a new device, product or procedure that solves a technical problem or has a practical advantage, there are different ways to protect it in Spain and other countries. Find out how.
Does your innovation lie in the aesthetics, ornamentation or appearance of your product? Protect it through industrial design. Find out what rights registration confers and how to proceed.
Geographical indications protect the name of a product that has a specific geographical origin and owes its qualities, characteristics or reputation to its particular origin. Find out what they are, how the registration process works and what benefits they provide.
Patents published worldwide are a valuable source of scientific, technical and commercial information.
El Bono 3 del Fondo para PYMEs 2025, que cubre la elaboración de Informes Tecnológicos de Patentes (ITP) y Búsquedas Retrospectivas se cerrará el lunes 10 de febrero de 2025 al cierre de la jornada laboral. Próximamente se informará sobre su reapertura. Puede consultar más información aquí.
If you are an entrepreneur or a company and you want to boost and improve the profitability of your business by adequately protecting the intangible assets of your organisation, in this space you will find what you need.
125
results.
Updated on
17/03/2026 [06:56:00]
Results 100 to 125 of 125
Absstract of: US20260024646A1
Disclosed herein are techniques related to product consumption recommendations. In some embodiments, the techniques may involve obtaining, for a patient, historical data comprising activity data, food consumption data, and glucose data. The techniques may further involve training a machine learning model to: predict glucose response parameters for the patient using the historical data as a training set; and utilize the predicted glucose response parameters to determine a recommendation associated with consumption of a product by the patient to maintain a glucose level within a target range during an activity.
Absstract of: US20260023141A1
The system can include: an array of magnets. In variants, the system can function to generate a homogenous magnetic field within a sample (e.g., in the pulp of a finger). In an example, the system can be used for nuclear magnetic resonance (NMR) imaging and/or magnetic resonance imaging (MRI). In a specific example, the system can be used to measure blood analyte levels (e.g., glucose levels) within a sample.
Absstract of: US20260020780A1
Certain aspects of the present disclosure provide systems and techniques for rapid detection of repetitive metabolic events in a host based on measured analyte data provided by an analyte monitor worn by the host. An example system is configured to obtain measured glucose data of the host. A subset of the measured glucose data is determined, based on performing a filtering operation on the measured glucose data. A respective range of a likelihood of an occurrence of a metabolic is determined for each value within the subset of the measured glucose data. For at least one value within the subset of the measured glucose data, a state of the metabolic event is determined based in part on at least one of an upper bound or a lower bound of the respective range corresponding to the at least one value within the subset of the measured glucose data.
Absstract of: US20260020779A1
The present disclosure relates to a method for manufacturing an insertion guide needle for a continuous blood glucose monitoring device. The present disclosure provides a method for manufacturing an insertion guide needle for a continuous blood glucose monitoring device, by which: an insertion guide needle can be manufactured through a cutting process and a bending process of a needle raw plate, so that a complicated manufacturing process is unnecessary, and can thus be easily manufactured through a simple process; an enlargement incision part for continuous enlargement and incision, etc. can be conveniently manufactured through such a simple processing process, so that a manufacturing cost thereof can be reduced and also the size accuracy of the insertion guide needle can be improved; and, particularly, in a process of inserting the insertion guide needle into skin, the insertion guide needle can be brought into point contact with the skin to cut the skin, and then can continuously cut the skin in an enlarged manner, so as to minimize pains which may occur in the process of inserting the insertion guide needle into the skin, thereby alleviating the sense of repulsion or tension at the time of using the continuous blood glucose monitoring device.
Absstract of: US20260020785A1
The present disclosure relates to a continuous blood glucose measurement body attachment unit, and provides a continuous blood glucose measurement body attachment unit, which is manufactured in an assembled state in an applicator so as to minimize separate additional operations, such that the body attachment unit can be attached to the body with only a simple operation of the applicator and, particularly, the body attachment unit has a wireless communication chip so as to be capable of communicating with an external terminal, thereby enabling simple and convenient usage without an additional operation in which a separate transmitter must be connected and enabling maintenance to be more easily performed, and after the body attachment unit is attached to the body, an operation starts by the control of a user, such that an operation start time point can be adjusted to an appropriate time point according to the needs of the user, and an operation can start in a stabilized state, such that blood glucose can be more accurately measured.
Absstract of: US20260020784A1
Simulating a user's metabolic system and predicting a blood glucose response based on a specified food intake event includes receiving characteristic data representative of specified user characteristics, converting said characteristic data into object data and utilising said object data and a master model to generate a personal digital model representative of said user's metabolic system, receiving food intake data representative of a said specified food intake event, obtaining or generating current glucose data for said user, inputting said food intake data to said personal digital model, and generating, using said personal digital model, a simulation of said user's metabolic system in response to said food intake data and generating a predicted blood glucose response to said specified food intake event, outputting data representative of said predicted blood glucose response, and utilising said data representative of said predicted blood glucose response to retrain said master model and said personal digital model.
Absstract of: US20260022183A1
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition to an anti-hIL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
Absstract of: US20260021185A1
An improved local anesthetic solution with diminished bitter taste includes an anesthetic agent, an anesthetic solution vehicle, and a bitterness suppressant. The bitterness suppressant includes one or more compounds selected from the group consisting of: a sugar selected from the group consisting of monosaccharide sugars, disaccharide sugars, polysaccharide sugars, and combinations of the any of the foregoing; sweet-tasting compounds; acids; amino acids; salts; miscellaneous suppressant substances; and combinations of any of the foregoing. The improved local anesthetic solution optionally includes one or more additional agents selected from the group consisting of: buffering agents; vasoconstrictors; preservative compounds; stabilizers; contrast media agents; and combinations of any of the foregoing.
Absstract of: US20260021256A1
One or more embodiments of the present disclosure may include an insulin delivery system that includes an insulin delivery device, a user interface that includes multiple user-selectable icons or buttons each representing different meal characteristics, memory to store one or more user-specific dosage parameter, and a processor in communication with the memory and adapted to receive blood glucose data. The processor may also be adapted to determine initial meal characteristics associated with each of the user-selectable icons or buttons based on at least one of the user-specific dosage parameters. The processor may also be adapted to update the meal characteristics associated with each of the user-selectable icons or buttons based upon the blood glucose data.
Absstract of: AU2024280120A1
Blood glucose level measurement includes a light source configured to irradiate light to a subject; a monochrome part configured to separate wavelength components of the light that is reflected and scattered from the subject; a light receiver configured to receive the light transmitted via the monochrome part and to generate electrical signals based on the received light; and a processor configured to extract information on the blood glucose level of the subject based on a frequency shift of the light due to the Raman effect.
Absstract of: AU2024335431A1
The present disclosure describes lactate-responsive sensors, sensing systems incorporating a lactate-responsive sensor, and methods of use thereof that would be beneficial for continuously monitoring lactate levels and determining lactate thresholds (both aerobic and anaerobic thresholds). The present disclosure also relates to an analyte sensor for continuously detecting glucose and lactate levels.
Absstract of: AU2024343861A1
A system includes an analyte measurement system and a software application operatively coupled to the analyte measurement system. The analyte measurement system is configured to measure a ketone level in the bodily fluid of a patient. The application is configured to display at least one of (1) a current ketone level and an indicator of a current ketone trend, (2) a ketone trend graph, and (3) a total amount of time that the ketone levels are above at least one predetermined threshold level. The application is also configured to determine if the current ketone level is above the at least one predetermined threshold level, and in response to determining that the current ketone level is above the at least one predetermined threshold level, output an alarm, wherein the alarm is outputted periodically while the current ketone level is above the at least one predetermined threshold level.
Absstract of: WO2025064417A1
Embodiments can relate to an insulin delivery controller which implements a processor configuration to efficiently attain an insulin delivery target. The insulin delivery controller can include a processor and a memory associated with the processor. The processor can process glucose data received from the memory, including a data representation of glycemic disturbance (d(t)). The processor can determine a glucose rate of change (G'(t)). The processor can generate a command signal to dynamically reshape a glycemic disturbance within a prediction horizon of the insulin delivery controller according to the G'(t). The processor can generate an insulin command signal for an insulin delivery unit to adjust an insulin delivery dosage amount and/or an insulin delivery dosage rate.
Absstract of: WO2026019913A1
In an embodiment, a method includes receiving analyte measurements of a patient for a time period. The method further includes providing, to a user, an interface for supplying contextual data indicative of contextual events for the time period and receiving the contextual data via the provided interface. The method further includes analyzing the analyte measurements and the contextual events to determine a condensed timeline of patient data for the time period, the condensed timeline of patient data including a partial subset of the contextual events. The method further includes presenting information related to the condensed timeline to the patient.
Absstract of: US20260022182A1
The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition to an anti-hIL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
Absstract of: WO2024192362A1
Embodiments relate to a control module for storing and accessing insulin delivery parameters to accurately set an insulin dosage amount. The control module can include a processor and a memory having instructions stored thereon that when executed by the processor will cause the processor to: receive glucose data including glucose concentration measurements spanning a time period; identify a minimum glucose concentration measurement (Gmin) within the time period; identify a current glucose concentration measurement (Gc); set an upper bound constraint based on the Gmin and the Gc; generate an adapted insulin dosage schedule by imposing a maximum insulin dosage on an insulin dosage schedule based on the upper bound constraint; and either: administer an insulin dosage in accordance with the adapted insulin dosage schedule; or control administration of insulin via an insulin dosage signal based on the adapted insulin dosage schedule.
Absstract of: EP4681641A2
The present invention relates to a sensor applicator assembly for a continuous glucose monitoring system and provides a sensor applicator assembly for a continuous glucose monitoring system, which is manufactured with a sensor module assembled inside an applicator, thereby minimizing additional work by a user for attaching the sensor module to the body and allowing the sensor module to be attached to the body simply by operating the applicator, and thus can be used more conveniently. A battery is built in the sensor module and a separate transmitter is connected to the sensor module so as to receive power supply from the sensor module and be continuously used semi-permanently, thereby making the assembly economical. The sensor module and the applicator are used as disposables, thereby allowing accurate and safe use and convenient maintenance.
Absstract of: CN223810750U
The utility model relates to the field of medical supplies, and discloses an application type insulin pump needle assisting device which comprises a base, a shell, a sliding piece, an energy storage assembly, a limiting piece and an excitation assembly, the base is used for being applied to the position where a needle needs to be applied, and a needle punching opening is formed in the base; the shell is detachably mounted on the base; the sliding piece is arranged in the shell in a sliding mode, and a puncture needle and a retention needle arranged on the puncture needle in a sleeving mode are arranged on the sliding piece; the energy storage assembly is used for driving the sliding piece to approach the needling opening to a first position and far away from the needling opening from the first position to a second position; the excitation assembly is used for preventing the limiting piece from rotating before being excited and allowing the limiting piece to rotate from the first angle to the second angle after being excited. The application type needle assisting device for the insulin pump is simple in structure, low in cost, capable of being used as a disposable consumable, safe, sanitary, compact in structure, portable and convenient to use.
Absstract of: CN223799775U
The utility model relates to the technical field of blood sampling prompters, in particular to a tip blood sampling prompter for blood glucose monitoring, which comprises a prompting plate body, six round button prompting pieces and a magnetic connecting piece, a transverse guide groove and a vertical guide groove which are transversely and vertically through are arranged on the prompting plate body, six accommodating grooves are arranged on the transverse guide groove and the vertical guide groove in an extending manner, and the magnetic connecting piece is arranged in the accommodating grooves. The six round button prompt pieces correspond to four fingers, left and right finger pulps and indication marks for distinguishing the left hand and the right hand of a patient respectively, and the round button prompt pieces can move along the transverse guide grooves and the vertical guide grooves so that the round button prompt pieces can be moved to any containing groove; based on the physiological recovery cycle and the medical principle, a reasonable finger rotation scheme can be formulated, it can be ensured that each monitored part has enough recovery time, and injuries and pains are reduced; the finger rotation condition can be clearly recorded and displayed, repeated use of the same finger in a short time is avoided, random blood sampling is reduced, and adverse reactions are reduced.
Absstract of: CN121343376A
The invention discloses PEDOT (poly (3, 4-ethylenedioxythiophene)) modified DNA (deoxyribonucleic acid) hydrogel, which is hydrogel with a three-dimensional network structure, which is formed by (1) PEDOT: a DNA compound and a cross-linking agent, or (2) PEDOT: a DNA compound, long-chain DNA and a cross-linking agent through cross-linking, the PEDOT: DNA compound is a compound which is formed by assembling poly (3, 4-ethylenedioxythiophene) and double-stranded DNA through electrostatic interaction; one chain of the double-chain DNA contains a recognition sequence of the biomarker, and the other chain of the double-chain DNA contains a sequence which is complementary with the recognition sequence of the biomarker and is partially mismatched with the recognition sequence of the biomarker. The invention also discloses an application of the PEDOT modified DNA hydrogel in preparation or as a capacitance material for monitoring a diabetes wound microenvironment. The PEDOT modified DNA hydrogel disclosed by the invention has good biocompatibility, wound protectiveness and capacitance responsiveness, can realize conversion from a biological signal to a capacitance signal, and has great application potential in the aspect of monitoring a diabetes wound microenvironment.
Absstract of: CN121338171A
The invention relates to an insulin pen needle dismounting device. The insulin pen needle dismounting device comprises a shell, a bevel gear set, a gear driving device and two clamping devices. A containing channel penetrates through the shell from the top to the bottom, and sliding grooves are formed in the inner top and the inner bottom of the shell. The bevel gear set is arranged in the shell and comprises a left bevel gear, a right bevel gear, an upper bevel gear and a lower bevel gear, and the upper portion and the lower portion of the left bevel gear and the upper portion and the lower portion of the right bevel gear are meshed with the upper bevel gear and the lower bevel gear; the gear driving device is connected with the right bevel gear; and the two clamping devices are respectively mounted in mounting holes of the upper bevel gear and the lower bevel gear. When the device is used for disassembling the insulin pen needle head, high-frequency daily needle taking work of hospital nurses and needle head separation operation after self-injection at home of patients and family members can be easily carried out, the needle head does not need to be touched by hands in the whole process, the pricking injury risk caused by needle taking by hands can be effectively avoided, and the working efficiency is improved. And the needle dismounting safety is improved.
Absstract of: CN121347499A
The invention discloses a silk fibroin-based glucose detection platform preparation method, which comprises: mixing cyclodextrin and deionized water to form a homogeneous solution, adding a buffer solution to adjust the pH value range to 4-8, adding 3, 3 ', 5, 5'-tetramethyl benzidine, and uniformly mixing under a dark condition to prepare a 3, 3 ', 5, 5'-tetramethyl benzidine cyclodextrin solution; uniformly mixing a structure regulator with the silk fibroin solution to form a homogeneous precursor solution; uniformly mixing the precursor solution with glucose oxidase, horse radish peroxidase and the 3, 3 ', 5, 5'-tetramethyl benzidine cyclodextrin solution to obtain a base solution; pouring the precursor solution on a microneedle mold, and drying and curing at normal temperature to obtain a microneedle tip; the base solution is poured into a mold containing a needle tip to form a base, demolding is conducted after drying, and the silk fibroin-based glucose detection platform is obtained.
Absstract of: CN121337321A
The invention discloses a blood glucose monitor transmitting device capable of preventing secondary use of a user and a continuous blood glucose monitor. According to the technical scheme, the blood glucose monitor transmitting device comprises a main body shell, a puncture unit, a triggering piece and a boosting structure, an opening is formed in one end of the main body shell, and the boosting structure has a locking state relative to the main body shell and a triggering state moving towards the tail end of the opening. The puncture unit and the boosting structure can move from the locking state position to the opening together, a first buckle is arranged between the puncture unit and the boosting structure and connected with the first buckle position, the puncture unit is arranged in the boosting structure in a sleeved mode, a first spring is arranged between the puncture unit and the boosting structure in advance, and a releasing structure is arranged in the main body shell. When the boosting structure and the puncturing unit move from the locking state position to the opening, the releasing structure abuts against the first buckle so that the first buckle can not be buckled with the first buckling position any more.
Absstract of: CN121358402A
The invention relates to a method for determining the concentration of a substance in a sample comprising a liquid comprising particles, in particular glucose in blood, in which the refractive index of the liquid depends on the concentration of the substance dissolved therein and the particle density in the liquid is substantially constant. The method includes obtaining a PPG first signal during a first time period and estimating a set of complex coefficients from the first obtained signal. The phase difference is determined from these coefficients or a subset thereof and then used to derive a substance concentration or a change in substance concentration.
Nº publicación: CN223799771U 16/01/2026
Applicant:
SUZHOU CITY WUJIANG DISTR HOSPITAL OF TCM TRADITIONAL CHINESE MEDICINE SUZHOU CITY WUJIANG DISTR NO
\u82CF\u5DDE\u5E02\u5434\u6C5F\u533A\u4E2D\u533B\u533B\u9662\uFF08\u82CF\u5DDE\u5E02\u5434\u6C5F\u533A\u7B2C\u4E8C\u4EBA\u6C11\u533B\u9662\uFF09
Absstract of: CN223799771U
The utility model relates to the technical field of blood glucose monitoring equipment, and discloses a portable blood glucose meter which comprises a main body assembly, a machine body, a display screen, control keys and test paper, the display screen and the control keys are arranged on one side of the machine body, a detection opening is formed in the end of the machine body, and the test paper is located in the machine body; the storage assembly is arranged on the machine body and comprises a storage box, a sealing cover, buckle plates and limiting buckles, the storage box is fixed to one side of the machine body, the sealing cover is located on one side of the storage box, and the buckle plates are fixed to the two sides of the sealing cover. The device has the beneficial effects that part of test paper can be stored on the machine body by arranging the storage assembly and the pop-up assembly, the test paper can be directly taken from the machine body when the test paper needs to be used, pollution to other test paper when the test paper is taken can be avoided by arranging the driving piece, and the test paper can be directly popped up after the test is finished, so that the test efficiency is improved. And manual pulling-out is not needed, so that infection is avoided.
BOPI
Electronic site
